E. Merck KG board of partners has announced the appointment of new CEOs to Merck KGaA’s executive board, aiding its ongoing ...

Belén Garijo (Almansa, 1960) is the CEO of the German giant Merck, which is valued at 240,000 million on the stock market, like Inditex and Banco Santander combined. This is how high this ...

Belén Garijo joined Merck in 2011 as chief operating officer of its biopharma division. She swiftly rose the ranks to CEO of its health care business sector in 2015, before taking the group’s ...

The CEO of Germany's Merck KGaA on Thursday said a recovery in sales growth at its existing business means it can take a cautious approach to buying other companies, which are expensively priced.

In an exclusive interview to the Economic Times, Belen Garijo, chief executive of Merck Serono, the biopharmaceutical business of Merck KGaA, said the market potential for her company's pharma and ...

"We need to move fast ... Europe (does not) lack ideas, it's an issue of implementation," said German Merck Group's CEO Belen Garijo, adding, however, that the catalyst for increasing competition ...

Garijo leads Merck KGaA, a global drug and sciences company with $23 billion in annual sales and a history that dates back to 1668—not to be confused with U.S. pharma giant Merck. Its top ...